{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T15:35:41Z","timestamp":1793028941166,"version":"4.5.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Reproductive Immunology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jri.2026.104890","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T16:34:48Z","timestamp":1775666088000},"page":"104890","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Recurrent pregnancy loss and targeted immunotherapy: Mechanistic insights and the role of biologic disease-modifying anti-rheumatic drugs"],"prefix":"10.1016","volume":"175","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9943-9731","authenticated-orcid":false,"given":"Marcelo Borges","family":"Cavalcante","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela Torres de Melo","family":"Cavalcante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"de Sousa Sobral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara Andryne Alves","family":"Aguiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Ewerton Maia","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leili","family":"Aghebati-Maleki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Kwak-Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jri.2026.104890_bib1","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.2174\/1381612829666230904150808","article-title":"Role of th17 and il-17 cytokines on inflammatory and auto-immune diseases","volume":"29","author":"Akhter","year":"2023","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jri.2026.104890_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2024.104295","article-title":"The impact of reproductive hormones on t cell immunity; normal and assisted reproductive cycles","volume":"165","author":"Alanazi","year":"2024","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2026.104890_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109130","article-title":"Interleukin-6 cytokine: An overview of the immune regulation, immune dysregulation, and therapeutic approach","volume":"111","author":"Aliyu","year":"2022","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.jri.2026.104890_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26020785","article-title":"A review of immunological evaluation of patients with recurrent spontaneous abortion (rsa)","volume":"26","author":"Andreescu","year":"2025","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.jri.2026.104890_bib5","article-title":"Eshre guideline: Recurrent pregnancy loss: an update in 2022","volume":"2023","author":"Bender Atik","year":"2023","journal-title":"Hum. Reprod. Open"},{"key":"10.1016\/j.jri.2026.104890_bib6","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.bbrc.2015.11.118","article-title":"Interleukin 23 regulates the functions of human decidual immune cells during early pregnancy","volume":"469","author":"Cai","year":"2016","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.jri.2026.104890_bib7","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1055\/s-0044-1795160","article-title":"A review of autoimmune thyroid diseases and their complex interplay with female fertility","volume":"42","author":"Carafone","year":"2024","journal-title":"Semin Reprod. Med"},{"key":"10.1016\/j.jri.2026.104890_bib8","article-title":"The use of immunotherapies for recurrent miscarriage: An overview of systematic reviews and meta-analysis","volume":"158","author":"Cavalcante","year":"2023","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2026.104890_bib9","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.3109\/14767058.2014.943175","article-title":"Risk factors associated with a new pregnancy loss and perinatal outcomes in cases of recurrent miscarriage treated with lymphocyte immunotherapy","volume":"28","author":"Cavalcante","year":"2015","journal-title":"J. Matern Fetal Neonatal Med"},{"key":"10.1016\/j.jri.2026.104890_bib10","doi-asserted-by":"crossref","DOI":"10.1111\/aji.70099","article-title":"2025 american society for reproductive immunology guidelines for the treatment of recurrent pregnancy losses: Practice recommendations from the asri clinical reproductive immunology fellowship","volume":"93","author":"Cavalcante","year":"2025","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2026.104890_bib11","article-title":"Immune biomarkers in cases of recurrent pregnancy loss and recurrent implantation failure","author":"Cavalcante","year":"2024","journal-title":"Minerva Obstet. Gynecol."},{"key":"10.1016\/j.jri.2026.104890_bib12","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13248","article-title":"Dose-dependent structural and immunological changes in the placenta and fetal brain in response to systemic inflammation during pregnancy","volume":"84","author":"Chudnovets","year":"2020","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2026.104890_bib13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/imr.12621","article-title":"Overview of the il-1 family in innate inflammation and acquired immunity","volume":"281","author":"Dinarello","year":"2018","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jri.2026.104890_bib14","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/biolre\/ioaa102","article-title":"The role of the il-1 system in pregnancy and the use of il-1 system markers to identify women at risk for pregnancy complications","volume":"103","author":"Equils","year":"2020","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.jri.2026.104890_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2021.103459","article-title":"Anti-ro\/ssa and\/or anti-la\/ssb antibodies are associated with adverse ivf and pregnancy outcomes","volume":"149","author":"Fang","year":"2022","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2026.104890_bib16","article-title":"Nlrp3 inflammasome and its critical role in gynecological disorders and obstetrical complications","volume":"11","author":"Fang","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.jri.2026.104890_bib17","series-title":"Us food and drug administration","author":"Fda","year":"2025"},{"key":"10.1016\/j.jri.2026.104890_bib18","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.cytogfr.2015.07.005","article-title":"Insights into il-23 biology: From structure to function","volume":"26","author":"Floss","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.jri.2026.104890_bib19","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.tjog.2019.07.007","article-title":"A randomized controlled trial of etanercept in the treatment of refractory recurrent spontaneous abortion with innate immune disorders","volume":"58","author":"Fu","year":"2019","journal-title":"Taiwan J. Obstet. Gynecol."},{"key":"10.1016\/j.jri.2026.104890_bib20","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/s41423-025-01358-8","article-title":"Il-1 family cytokines in inflammation and immunity","volume":"22","author":"Garlanda","year":"2025","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.jri.2026.104890_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26031295","article-title":"Exploring the immunological aspects and treatments of recurrent pregnancy loss and recurrent implantation failure","volume":"26","author":"Garmendia","year":"2025","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.jri.2026.104890_bib22","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.fertnstert.2023.08.954","article-title":"The prevalence of sporadic and recurrent pregnancy loss","volume":"120","author":"Genovese","year":"2023","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jri.2026.104890_bib23","doi-asserted-by":"crossref","first-page":"792","DOI":"10.4014\/jmb.2112.12056","article-title":"Il-23 inhibits trophoblast proliferation, migration, and emt via activating p38 mapk signaling pathway to promote recurrent spontaneous abortion","volume":"32","author":"He","year":"2022","journal-title":"J. Microbiol Biotechnol."},{"key":"10.1016\/j.jri.2026.104890_bib24","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-023-01620-3","article-title":"The il-17 family in diseases: From bench to bedside","volume":"8","author":"Huangfu","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.jri.2026.104890_bib25","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1111\/jcpt.13771","article-title":"Tumour necrosis factor inhibitor combined with intravenous immunoglobulin and heparin for treatment of recurrent spontaneous abortion: A two-centre, retrospective, cohort study","volume":"47","author":"Jiang","year":"2022","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.jri.2026.104890_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/aji.70125","article-title":"Evaluation of th1-th2 balance in patients with unexplained recurrent spontaneous abortion: A systematic review and meta-analysis","volume":"94","author":"Kargar","year":"2025","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2026.104890_bib27","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1600-0897.2010.00911.x","article-title":"Thyroid autoimmunity and its association with cellular and humoral immunity in women with reproductive failures","volume":"65","author":"Kim","year":"2011","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2026.104890_bib28","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/aji.12208","article-title":"Intravenous immunoglobulin g modulates peripheral blood th17 and foxp3(+) regulatory t cells in pregnant women with recurrent pregnancy loss","volume":"71","author":"Kim","year":"2014","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2026.104890_bib29","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.fertnstert.2014.03.037","article-title":"Interleukin-1beta -511t>c genetic variant contributes to recurrent pregnancy loss risk and peripheral natural killer cell proportion","volume":"102","author":"Kim","year":"2014","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jri.2026.104890_bib30","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.fertnstert.2022.04.009","article-title":"The role of immunologic tests for subfertility in the clinical environment","volume":"117","author":"Kwak-Kim","year":"2022","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jri.2026.104890_bib31","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/humrep\/deg156","article-title":"Increased t helper 1 cytokine responses by circulating t cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after ivf","volume":"18","author":"Kwak-Kim","year":"2003","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.jri.2026.104890_bib32","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1600-0897.2007.00506.x","article-title":"Elevated th1\/th2 cell ratios in a pregnant woman with a history of rsa, secondary sj\u00f6gren's syndrome and rheumatoid arthritis complicated with one fetal demise of twin pregnancy","volume":"58","author":"Kwak-Kim","year":"2007","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2026.104890_bib33","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.autrev.2016.07.015","article-title":"Humoral and cellular autoimmunity in women with recurrent pregnancy losses and repeated implantation failures: A possible role of vitamin d","volume":"15","author":"Kwak-Kim","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jri.2026.104890_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-13772-z","article-title":"Health professionals require more defined protocols, better funding and patient resources to support couples with recurrent pregnancy loss","volume":"15","author":"Ledowsky","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jri.2026.104890_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2021.103283","article-title":"Interleukin-1 beta is significantly upregulated in the decidua of spontaneous and recurrent miscarriage placentas","volume":"144","author":"L\u00f6b","year":"2021","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2026.104890_bib36","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S2213-2600(21)00103-X","article-title":"Interleukin-6: Obstacles to targeting a complex cytokine in critical illness","volume":"9","author":"Mcelvaney","year":"2021","journal-title":"Lancet Respir. Med"},{"key":"10.1016\/j.jri.2026.104890_bib37","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.reuma.2023.02.003","article-title":"Safety and effectiveness of bdmards during pregnancy in patients with rheumatic diseases: Real-world data from the biobadaser registry","volume":"19","author":"Membrive-Jim\u00e9nez","year":"2023","journal-title":"Reum. Clin. (Engl. Ed."},{"key":"10.1016\/j.jri.2026.104890_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232213913","article-title":"Therapeutic utility and adverse effects of biologic disease-modifying anti-rheumatic drugs in inflammatory arthritis","volume":"23","author":"Min","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.jri.2026.104890_bib39","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cyto.2016.08.014","article-title":"Molecular mechanisms of action of anti-tnf-\u03b1 agents - comparison among therapeutic tnf-\u03b1 antagonists","volume":"101","author":"Mitoma","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.jri.2026.104890_bib40","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13939","article-title":"Unexplained recurrent pregnancy loss: Clinical application of immunophenotyping","volume":"92","author":"Monticciolo","year":"2024","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2026.104890_bib41","first-page":"425","article-title":"Review article: The immune system in pregnancy: A unique complexity","volume":"63","author":"Mor","year":"2010"},{"key":"10.1016\/j.jri.2026.104890_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2024.152808","article-title":"The safety and efficacy of tumor necrosis factor-alpha inhibitor on pregnancy outcomes in patients with unexplained recurrent miscarriage","volume":"229","author":"Mu","year":"2024","journal-title":"Immunobiology"},{"key":"10.1016\/j.jri.2026.104890_bib43","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.3109\/14767058.2015.1085964","article-title":"Does the presence of autoantibodies without autoimmune diseases and hereditary thrombophilia have an effect on recurrent pregnancy loss?","volume":"29","author":"Mumusoglu","year":"2016","journal-title":"J. Matern Fetal Neonatal Med"},{"key":"10.1016\/j.jri.2026.104890_bib44","doi-asserted-by":"crossref","first-page":"5719","DOI":"10.1007\/s11033-014-3443-8","article-title":"Association of interleukin 1 receptor antagonist (il1rn) gene polymorphism with recurrent pregnancy loss risk in the north indian population and a meta-analysis","volume":"41","author":"Nair","year":"2014","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.jri.2026.104890_bib45","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.fertnstert.2014.06.010","article-title":"Elevation of soluble form of receptor for advanced glycation end products (srage) in recurrent pregnancy losses (rpl): Possible participation of rage in rpl","volume":"102","author":"Ota","year":"2014","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jri.2026.104890_bib46","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1093\/humrep\/det233","article-title":"Altered expression of interleukin-6, interleukin-8 and their receptors in decidua of women with sporadic miscarriage","volume":"28","author":"Pitman","year":"2013","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.jri.2026.104890_bib47","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.ard.2025.02.021","article-title":"Antirheumatic drugs in reproduction, pregnancy, and lactation: A systematic literature review informing the 2024 update of the eular recommendations","volume":"84","author":"Pluma","year":"2025","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jri.2026.104890_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jri.2012.05.004","article-title":"Interleukin-6 in pregnancy and gestational disorders","volume":"95","author":"Prins","year":"2012","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2026.104890_bib49","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/S0140-6736(21)00682-6","article-title":"Miscarriage matters: The epidemiological, physical, psychological, and economic costs of early pregnancy loss","volume":"397","author":"Quenby","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jri.2026.104890_bib50","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1111\/aogs.13210","article-title":"Is the incidence of recurrent pregnancy loss increasing? A retrospective register-based study in sweden","volume":"96","author":"Rasmark Roepke","year":"2017","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.jri.2026.104890_bib51","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.8755-8920.2000.430304.x","article-title":"Interleukin-1 stimulates human uterine prostaglandin production through induction of cyclooxygenase-2 expression","volume":"43","author":"Rauk","year":"2000","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2026.104890_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22062922","article-title":"The role of tnf-\u03b1 and anti-tnf-\u03b1 agents during preconception, pregnancy, and breastfeeding","volume":"22","author":"Romanowska-Pr\u00f3chnicka","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.jri.2026.104890_bib53","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.ard.2025.02.023","article-title":"Eular recommendations for use of antirheumatic drugs in reproduction, pregnancy, and lactation: 2024 update","volume":"84","author":"R\u00fcegg","year":"2025","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jri.2026.104890_bib54","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1600-0897.2010.00852.x","article-title":"Th1\/th2\/th17 and regulatory t-cell paradigm in pregnancy","volume":"63","author":"Saito","year":"2010","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2026.104890_bib55","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cytogfr.2025.01.002","article-title":"Interleukin-17: A pleiotropic cytokine implicated in inflammatory, infectious, and malignant disorders","volume":"83","author":"Saran","year":"2025","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.jri.2026.104890_bib56","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41584-023-01002-7","article-title":"Tnf and tnf receptors as therapeutic targets for rheumatic diseases and beyond","volume":"19","author":"Siegmund","year":"2023","journal-title":"Nat. Rev. Rheuma"},{"key":"10.1016\/j.jri.2026.104890_bib57","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12916-024-03309-y","article-title":"Autoimmune diseases and adverse pregnancy outcomes: An umbrella review","volume":"22","author":"Singh","year":"2024","journal-title":"BMC Med"},{"key":"10.1016\/j.jri.2026.104890_bib58","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/annrheumdis-2013-204317","article-title":"Proposal for a new nomenclature of disease-modifying antirheumatic drugs","volume":"73","author":"Smolen","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jri.2026.104890_bib59","article-title":"Endogenous and exogenous cytokines: An overview and introduction","volume":"38","author":"Spitzer","year":"2025","journal-title":"Best. Pr. Res Clin. Haematol."},{"key":"10.1016\/j.jri.2026.104890_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2021.103369","article-title":"Reproductive outcomes of women with recurrent pregnancy losses and repeated implantation failures are significantly improved with immunomodulatory treatment","volume":"148","author":"Sung","year":"2021","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2026.104890_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314574","article-title":"Il-6 and il-8: An overview of their roles in healthy and pathological pregnancies","volume":"23","author":"Viloti\u0107","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.jri.2026.104890_bib62","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.3389\/fimmu.2020.02025","article-title":"T helper (th) cell profiles in pregnancy and recurrent pregnancy losses: Th1\/th2\/th9\/th17\/th22\/tfh cells","volume":"11","author":"Wang","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.jri.2026.104890_bib63","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1600-0897.2008.00669.x","article-title":"Treatment with adalimumab (humira) and intravenous immunoglobulin improves pregnancy rates in women undergoing ivf","volume":"61","author":"Winger","year":"2009","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2026.104890_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.982238","article-title":"The regulatory mechanism and potential application of il-23 in autoimmune diseases","volume":"13","author":"Xiong","year":"2022","journal-title":"Front Pharm."},{"key":"10.1016\/j.jri.2026.104890_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010132","article-title":"The update immune-regulatory role of pro- and anti-inflammatory cytokines in recurrent pregnancy losses","volume":"24","author":"Yang","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.jri.2026.104890_bib66","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1210\/en.2017-00495","article-title":"Il-1\u03b2 inhibits connexin 43 and disrupts decidualization of human endometrial stromal cells through erk1\/2 and p38 map kinase","volume":"158","author":"Yu","year":"2017","journal-title":"Endocrinology"},{"key":"10.1016\/j.jri.2026.104890_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2022.103785","article-title":"Unexplained recurrent pregnancy loss: Novel causes and advanced treatment","volume":"155","author":"Yu","year":"2023","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2026.104890_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2022.103776","article-title":"Tnf\u03b1\/tnfr1 signal induces excessive senescence of decidua stromal cells in recurrent pregnancy loss","volume":"155","author":"Zeng","year":"2023","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2026.104890_bib69","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1210\/clinem\/dgaf283","article-title":"Dyslipidemia is associated with increased natural killer cell cytotoxicity and autoimmunity in women with recurrent pregnancy losses","volume":"111","author":"Zhang","year":"2025","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jri.2026.104890_bib70","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/aji.12447","article-title":"Association between serum tnf-\u03b1 levels and recurrent spontaneous miscarriage: A meta-analysis","volume":"75","author":"Zhang","year":"2016","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2026.104890_bib71","article-title":"Role of decidual natural killer cells in human pregnancy and related pregnancy complications","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.jri.2026.104890_bib72","article-title":"Association between genetic polymorphisms in interleukin genes and recurrent pregnancy loss - a systematic review and meta-analysis","volume":"12","author":"Zhang","year":"2017","journal-title":"PLoS One"}],"container-title":["Journal of Reproductive Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165037826000598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165037826000598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T21:08:53Z","timestamp":1783026533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165037826000598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":72,"alternative-id":["S0165037826000598"],"URL":"https:\/\/doi.org\/10.1016\/j.jri.2026.104890","relation":{},"ISSN":["0165-0378"],"issn-type":[{"value":"0165-0378","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recurrent pregnancy loss and targeted immunotherapy: Mechanistic insights and the role of biologic disease-modifying anti-rheumatic drugs","name":"articletitle","label":"Article Title"},{"value":"Journal of Reproductive Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jri.2026.104890","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104890"}}